Research Hub

Aspergillosis research is evolving rapidly, including antifungal development, biologics,
diagnostic tools and airway clearance research.
This hub summarises the latest studies, evidence and emerging science.


Topics in This Hub

Latest Research Articles

🧪 Why New Antifungal Trials Start with Invasive Aspergillosis

November 11, 2025

🩺 Why New Antifungal Medicines Aren’t for Everyone (Yet)

November 11, 2025

🌿 New Antifungal Medicines on the Horizon: Olorofim and Fosmanogepix

November 11, 2025

Understanding Risk from Aspergillosis — and What’s Improving

November 10, 2025

🫁 Understanding Chronic Cough in Aspergillosis

October 30, 2025

🧬 Article 2: When Microbes Turn Hostile – The Evolutionary Pressures Behind Infection

October 30, 2025

🧬 From Scottish Discovery to American Pharmacy Shelf: The Story of Brensocatib

October 27, 2025

🧩 NAC Aspergillosis Research Digest Aspergillosis (October 2025: week 44)

October 27, 2025

🌬️ Inhaled Antifungal Treatments for Chronic Pulmonary Aspergillosis (CPA)

October 23, 2025

🧬 The Story of Brensocatib: A New Way to Calm Lung Inflammation

October 21, 2025

🧩 NAC Aspergillosis Research Digest Aspergillosis (October 2025: week 43)

October 20, 2025

🧩 NAC Aspergillosis Research Digest — Focus: Chronic Aspergillosis (October 2025: week 42)

October 13, 2025

🧠 Understanding Regulatory T Cells (Tregs) in Aspergillosis

October 6, 2025

🔍 Aspergillosis: Recent Highlights & Key Publications October 2025 (Week 41)

October 6, 2025

🌟 Biologics and the Future: A Toolkit for Severe Asthma, ABPA & Beyond

September 24, 2025

Mast Cell Activation Syndrome (MCAS), Mastocytosis, and Aspergillosis: What Patients Need to Know

September 17, 2025

National Aspergillosis Centre Video Recordings

September 8, 2025

Brensocatib for Aspergillosis Patients: A New Approach to Managing Bronchiectasis and Inflammation

August 11, 2025

Debate: Gender Bias in Science and Clinical Trials & Why It Matters to Patients

August 7, 2025

💬 What Would Help You Consider Taking Part in a Clinical Trial?

August 6, 2025

🦠 Understanding Antibiotic Use in Aspergillosis: A Guide to Antimicrobial Stewardship (AMS)

August 6, 2025

💡 Dupilumab for ABPA: What You Need to Know Now the Trial Is Complete

August 1, 2025

🤐 Why It’s Important Not to Share Your Clinical Trial Experience — Until It’s Over

August 1, 2025

🧾 Rezafungin: A New Antifungal Being Trialled for CPA

August 1, 2025

🔬 Emerging Research for Aspergillosis

July 30, 2025

🫁 Could Lung or Nasal Coatings Help Prevent Aspergillosis?

July 30, 2025

Biologics and Long Term Side Effects

July 14, 2025

🛡️ How Your Care is Changing: Understanding Antimicrobial Stewardship

July 14, 2025

💊 General Strategies to Reduce Antimicrobial Resistance in Clinical Practice

July 14, 2025

🦠 Antifungal Resistance: What It Is, How It Happens, and Why It Matters

July 14, 2025

Article 4: Why This New Information on Biofilms Can Be Reassuring — Not Frightening

July 8, 2025

📝 Article 3: When Microbes Work Together – Aspergillus, Pseudomonas, and Lung Inflammation

July 8, 2025

📝 Article 2: The Lung Microbiome – More Than Just Aspergillus

July 8, 2025

📝 Article 1: What Are Biofilms – And Why Do They Matter in Aspergillosis?

July 8, 2025

🧪 Why Are Some Studies So Small?

July 4, 2025

🧪 A Patient’s Guide to Understanding Clinical Research

July 4, 2025

Related Hubs

Did this page help you?

Tell us in one minute